스페클립스 주식회사 이미지

Speclipse, Inc.

Speclipse was established to make it easier for people to diagnose disease.
Our company was chosen as one of the "2018 TOP 10 Dermatology Solution Providers" by MedTech Outlook, a healthcare magazine in the US, for our technology that analyzes skin cancer based on Speclipse's laser-induced plasma spectroscopy and AI.
Speclipse is growing into a global medical device company that conducts research to expand the medical application of technology into the blood market, starting with skin cancer.

USA

  • 310 De Guigne Dr Sunnyvale, California 94085 USA
WEBSITE